Want to see HK:3869 full AI Analyst Report?
Hospital Corporation of China Ltd (3869) Ratios
Hospital Corporation of China Ltd Ratios
HK:3869's free cash flow for Q4 2025 was $108.56M. For the 2025 fiscal year, HK:3869's free cash flow was decreased by $-8.68M and operating cash flow was $117.24M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.62 | 0.61 | 1.31 | 0.47 | 2.23 |
| Quick Ratio | 1.59 | 0.59 | 1.24 | 0.44 | 2.14 |
| Cash Ratio | 0.98 | 0.39 | 0.72 | 0.28 | 0.84 |
| Solvency Ratio | 0.11 | 0.01 | 0.10 | -0.21 | -0.12 |
| Operating Cash Flow Ratio | 0.23 | 0.12 | 0.11 | 0.08 | 0.25 |
| Short-Term Operating Cash Flow Coverage | 2.19 | 0.19 | 0.92 | 0.13 | 1.58 |
| Net Current Asset Value | $ -757.59M | $ -908.37M | $ -957.39M | $ -1.15B | $ -812.31M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.41 | 0.45 | 0.42 | 0.45 | 0.35 |
| Debt-to-Equity Ratio | 2.10 | 3.41 | 2.74 | 4.32 | 1.36 |
| Debt-to-Capital Ratio | 0.68 | 0.77 | 0.73 | 0.81 | 0.58 |
| Long-Term Debt-to-Capital Ratio | 0.66 | 0.00 | 0.71 | 0.00 | 0.55 |
| Financial Leverage Ratio | 5.13 | 7.65 | 6.59 | 9.52 | 3.91 |
| Debt Service Coverage Ratio | 1.87 | 0.17 | 2.55 | -0.42 | -3.49 |
| Interest Coverage Ratio | 0.00 | 70.54 | 87.37 | -109.59 | -71.42 |
| Debt to Market Cap | 0.97 | 1.31 | 1.28 | 1.11 | 0.96 |
| Interest Debt Per Share | 5.25 | 8.43 | 7.60 | 8.02 | 7.90 |
| Net Debt to EBITDA | 2.13 | 1.85 | 1.81 | -1.31 | -1.61 |
| Profitability Margins | |||||
| Gross Profit Margin | 18.19% | 19.12% | 16.77% | 13.20% | 41.17% |
| EBIT Margin | 8.20% | 12.50% | 15.45% | -46.17% | -85.15% |
| EBITDA Margin | 12.44% | 16.40% | 19.86% | -40.64% | -77.24% |
| Operating Profit Margin | 8.24% | 12.61% | 15.02% | -47.07% | -83.62% |
| Pretax Profit Margin | 12.68% | 4.25% | 15.14% | -46.60% | -86.32% |
| Net Profit Margin | 9.27% | -2.68% | 9.20% | -42.08% | -53.95% |
| Continuous Operations Profit Margin | 9.45% | 0.96% | 11.79% | -46.25% | -69.65% |
| Net Income Per EBT | 73.11% | -63.05% | 60.77% | 90.30% | 62.50% |
| EBT Per EBIT | 153.87% | 33.69% | 100.80% | 99.00% | 103.22% |
| Return on Assets (ROA) | 5.29% | -1.50% | 5.26% | -19.75% | -8.99% |
| Return on Equity (ROE) | 27.14% | -11.44% | 34.66% | -188.08% | -35.18% |
| Return on Capital Employed (ROCE) | 6.39% | 23.55% | 12.09% | -82.79% | -16.75% |
| Return on Invested Capital (ROIC) | 4.58% | 2.13% | 8.95% | -30.56% | -13.08% |
| Return on Tangible Assets | 9.40% | -2.68% | 10.02% | -38.86% | -19.36% |
| Earnings Yield | 12.79% | -4.42% | 16.31% | -48.66% | -24.97% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.55 | 5.66 | 10.68 | 7.22 | 2.02 |
| Payables Turnover | 7.27 | 2.95 | 3.04 | 2.63 | 2.22 |
| Inventory Turnover | 53.58 | 37.48 | 23.11 | 17.38 | 6.37 |
| Fixed Asset Turnover | 5.94 | 6.78 | 6.31 | 5.01 | 1.98 |
| Asset Turnover | 0.57 | 0.56 | 0.57 | 0.47 | 0.17 |
| Working Capital Turnover Ratio | -10.10 | -5.93 | -3.98 | -7.80 | 0.73 |
| Cash Conversion Cycle | 22.46 | -49.41 | -69.92 | -67.01 | 73.17 |
| Days of Sales Outstanding | 65.82 | 64.43 | 34.17 | 50.57 | 180.47 |
| Days of Inventory Outstanding | 6.81 | 9.74 | 15.79 | 21.00 | 57.28 |
| Days of Payables Outstanding | 50.17 | 123.58 | 119.89 | 138.57 | 164.58 |
| Operating Cycle | 72.63 | 74.17 | 49.96 | 71.56 | 237.75 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.79 | 1.55 | 0.60 | 1.04 | 0.96 |
| Free Cash Flow Per Share | 0.68 | 1.44 | 0.49 | 0.92 | 0.85 |
| Dividend Paid and CapEx Coverage Ratio | 7.34 | 13.95 | 5.41 | 8.60 | 2.86 |
| Capital Expenditure Coverage Ratio | 7.34 | 13.95 | 5.41 | 8.60 | 8.42 |
| Operating Cash Flow Coverage Ratio | 0.15 | 0.18 | 0.08 | 0.13 | 0.12 |
| Operating Cash Flow to Sales Ratio | 0.11 | 0.15 | 0.06 | 0.13 | 0.26 |
| Free Cash Flow Yield | 12.88% | 22.54% | 8.37% | 12.80% | 10.43% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 15.59 | -22.61 | 6.13 | -2.06 | -4.01 |
| Price-to-Sales (P/S) Ratio | 0.72 | 0.61 | 0.56 | 0.86 | 2.16 |
| Price-to-Book (P/B) Ratio | 2.12 | 2.59 | 2.12 | 3.87 | 1.41 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 7.77 | 4.44 | 11.95 | 7.81 | 9.59 |
| Price-to-Operating Cash Flow Ratio | 6.71 | 4.12 | 9.74 | 6.91 | 8.45 |
| Price-to-Earnings Growth (PEG) Ratio | -0.07 | 0.18 | -0.05 | -0.03 | 0.13 |
| Enterprise Value Multiple | 7.96 | 5.55 | 4.65 | -3.43 | -4.40 |
| Enterprise Value | 1.46B | 1.31B | 1.32B | 1.59B | 1.77B |
| EV to EBITDA | 7.96 | 5.55 | 4.65 | -3.43 | -4.40 |
| EV to Sales | 0.99 | 0.91 | 0.92 | 1.40 | 3.40 |
| EV to Free Cash Flow | 10.61 | 6.66 | 19.57 | 12.61 | 15.09 |
| EV to Operating Cash Flow | 9.17 | 6.18 | 15.95 | 11.14 | 13.30 |
| Tangible Book Value Per Share | 3.58 | -4.13 | -4.35 | -5.46 | -3.89 |
| Shareholders’ Equity Per Share | 2.50 | 2.47 | 2.77 | 1.85 | 5.77 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.25 | 0.77 | 0.22 | 0.01 | 0.19 |
| Revenue Per Share | 7.31 | 10.53 | 10.44 | 8.27 | 3.76 |
| Net Income Per Share | 0.68 | -0.28 | 0.96 | -3.48 | -2.03 |
| Tax Burden | 0.73 | -0.63 | 0.61 | 0.90 | 0.63 |
| Interest Burden | 1.55 | 0.34 | 0.98 | 1.01 | 1.01 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.08 | 0.08 | 0.09 | 0.08 | 0.18 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 |
| Income Quality | 1.20 | 3.46 | 0.38 | -0.27 | -0.30 |
Currency in CNY
